Alder Therapeutics secured 20 MSEK seed financing from two top tier Swedish life-science investors Flerie Invest AB and Linc AB (publ). Upon reaching certain development milestones, Alder will receive an additional 14.4 MSEK
. The proceeds will be used to develop two of Alder’s initial stem cell therapy programs and to build the team to drive these programs forward.
Read the whole pressrelease here (PDF)